The following pages link to Pavel Mozgunov (Q830088):
Displaying 18 items.
- Response adaptive designs for phase II trials with binary endpoint based on context-dependent information measures (Q830089) (← links)
- (Q3295375) (← links)
- Using a dose‐finding benchmark to quantify the loss incurred by dichotomization in Phase II dose‐ranging studies (Q4998796) (← links)
- Loss functions in restricted parameter spaces and their Bayesian applications (Q5034175) (← links)
- An Information Theoretic Approach for Selecting Arms in Clinical Trials (Q5087173) (← links)
- An Information Theoretic Phase I–II Design for Molecularly Targeted Agents That Does Not Require an Assumption of Monotonicity (Q5116181) (← links)
- A flexible design for advanced Phase I/II clinical trials with continuous efficacy endpoints (Q5213412) (← links)
- (Q5360859) (← links)
- (Q5744199) (← links)
- A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability‐nonexchangeability method (Q6149277) (← links)
- An information-theoretic approach for selecting arms in clinical trials (Q6289896) (← links)
- Response-adaptive randomization for multiarm clinical trials using context-dependent information measures (Q6595096) (← links)
- A multi-arm multi-stage platform design that allows preplanned addition of arms while still controlling the family-wise error (Q6618368) (← links)
- A Bayesian multi-arm multi-stage clinical trial design incorporating information about treatment ordering (Q6625823) (← links)
- Improving safety of the continual reassessment method via a modified allocation rule (Q6627502) (← links)
- An order restricted multi-arm multi-stage clinical trial design (Q6628045) (← links)
- Practical implementation of the partial ordering continual reassessment method in a phase I combination-schedule dose-finding trial (Q6629425) (← links)
- An information theoretic phase I--II design for molecularly targeted agents that does not require an assumption of monotonicity (Q6642059) (← links)
